Aceto Corp.

Company News

ACETO to Appeal U.S. Government Ruling Regarding Certain Lucid Pharma Contracts

PORT WASHINGTON, N.Y., Feb. 27, 2018 - ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, has been notified by the U.S. government that 11 generic drug products it acquired through its Acetris Health subsidiary in a product purchase agreement with an...

Read More »
People in the News

ACETO Appoints Edward J. Borkowski Chief Financial Officer

PORT WASHINGTON, N.Y., Feb. 16, 2018 - ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed Edward J. Borkowski as Chief Financial Officer effective February 21, 2018. “Ed brings the right combination of pharmaceutical...

Read More »

All Topics